Pathology and Antibodies Working Group
The overarching objective of the Pathology Working Group is to prospectively classify screen- detected cancers at biopsy which are non-lethal. Recognizing that this is likely to involve combined data from genomics and immunology assays, the MCL Pathology WG aims to bring consistency to methodology and analysis criteria to compare and integrate data among MCL laboratories.
https://mcl.nci.nih.gov/working-groups-new/pathology-and-antibodies-working-group
https://mcl.nci.nih.gov/@@site-logo/Screen Shot 2015-10-11 at 5.09.05 PM.png
Pathology and Antibodies Working Group
The overarching objective of the Pathology Working Group is to prospectively classify screen- detected cancers at biopsy which are non-lethal. Recognizing that this is likely to involve combined data from genomics and immunology assays, the MCL Pathology WG aims to bring consistency to methodology and analysis criteria to compare and integrate data among MCL laboratories.
